The level above maximum safety concentration would lead to toxicity and level below the minimum effective concentration results in lack of efficacy.
Based on their variable minimum inhibitory concentration results, 40 differentiated isolates from various STM exposures were selected to check the prevalence of nine aminoglycoside resistance genes (aac(3 -II, aacA4, aadA, aadB, aadE, aphA1, aphA2, strA and strB) and two class I integron genes (3 -II aacA4ntI).
Prolonged exposure of C. jejuni to BPE resulted the minimum inhibitory concentration (MIC) of BPE to increase from 0.5 to 1.0 mg GAE/mL; however, after single sub-culture in BPE-free broth, the MIC value revived to 0.5 mg GAE/mL.
Resistance to penicillin, therefore, was modeled as an incremental point mutation process that increases the minimum inhibitory concentration of the resulting strain.
Results of the bactericidal activity are shown in Table 1; the minimum inhibitory concentration (MIC) results are expressed as µg/L inhibition.
Consistent with the microbial growth inhibition data depicted in Fig. 2, the effect of ACV at the minimum inhibitory concentration of 1/50 resulted in a significant reduction in monocyte derived TNFα (p = 0.008) and IL-6 release (P = 0.001) in monocytes cultured with E-coli.
No significant change in three measured physiological parameters was observed for most healthy murine tissues, despite the fact that the chosen dosage of B20-4.1 was based on previously reported xenograft growth inhibition activity [16] that should result in a minimum trough concentration at steady state of ∼30 µg/mL, similar to that achieved in >90% of bevacizumab patients [17].
In addition, a pharmacokinetic model simulation indicated that either a 5 mg/kg twice a week or 10 mg/kg weekly dosing regimen would result in a minimum trough concentration at steady state of ∼30 µg/mL, similar to that achieved in >90% of bevacizumab patients [17].
The minimum inhibition concentration (MIC) results revealed that most of the 2,6-diaryl-1- prop-2-yn-1-yl piperidin-4-one oximes (17, 19, 2,6-diaryl-1- prop-2-yn-1-yl piperidin-4-one the selected bacterial and fungal strains.
The results of minimum inhibitory concentration (MIC) are presented in Table 4.
Minimum bactericidal concentration (MBC) results revealed that WARDEEP exhibited minimum antibiotic activity at 25 mg/mL concentration against Proteus and Streptococcus species.
